Skip to main content

CODEXIS, INC.

For the period ended Sep 30, 2026. Filed Nov 12, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 12, 2026

CDXS$0.96-1.9%Stored close · as of Nov 12, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders' Equity

Checking your notes…

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders' Equity
Three Months Ended September 30, 2026 · Shares · Amount
Balance as of June 30, 202691,388$9$660,451$(13)$(627,489)$32,958
Issuance of common stock upon release of stock awards132—————
Issuance of common stock in connection with an equity offering, net of issuance costs of $2,09818,000224,900——24,902
Stock-based compensation——1,548——1,548
Net loss————(8,128)(8,128)
Other comprehensive loss———(42)—(42)
Balance as of September 30, 2026109,520$11$686,899$(55)$(635,617)$51,238
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders' Equity
Three Months Ended September 30, 2025 · Shares · Amount
Balance as of June 30, 202590,254$9$652,391$(3)$(596,766)$55,631
Issuance of common stock upon release of stock awards27—————
Stock-based compensation——2,513——2,513
Net loss————(19,615)(19,615)
Other comprehensive income———15—15
Balance as of September 30, 202590,281$9$654,904$12$(616,381)$38,544

Condensed Consolidated Statements of Stockholders' Equity

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders' Equity
Nine Months Ended September 30, 2026 · Shares · Amount
Balance as of December 31, 202590,478$9$657,292$8$(606,780)$50,529
Issuance of common stock upon release of stock awards945—————
Issuance of common stock under employee stock purchase plan97—148——148
Issuance of common stock in connection with an equity offering, net of issuance costs of $2,09818,000224,900——24,902
Stock-based compensation——4,559——4,559
Net loss————(28,837)(28,837)
Other comprehensive loss———(63)—(63)
Balance as of September 30, 2026109,520$11$686,899$(55)$(635,617)$51,238
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders' Equity
Nine Months Ended September 30, 2025 · Shares · Amount
Balance as of December 31, 202481,850$8$629,673$52$(562,806)$66,927
Issuance of common stock upon exercise of stock options339—1,049——1,049
Issuance of common stock upon release of stock awards696—————
Issuance of common stock under employee stock purchase plan151—317——317
Issuance of common stock in connection with an equity sales agreement, net of issuance costs of $8267,245116,441——16,442
Stock-based compensation——7,424——7,424
Net loss————(53,575)(53,575)
Other comprehensive loss———(40)—(40)
Balance as of September 30, 202590,281$9$654,904$12$(616,381)$38,544
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.